1. Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis
2. Janssen Pharmaceuticals, Inc. SPRAVATO® (Esketamine) Nasal Spray, CIII [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc; 2020.
3. US Food and Drug Administration. FDA Alerts Health Care Professionals of Potential Risks Associated with Compounded Ketamine Nasal Spray. US Food and Drug Administration Home Page; 2022. Available from: https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-professionals-potential-risks-associated-compounded-ketamine-nasal-spray. Accessed June 23, 2023.